Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: Q4Q5S6
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0016791 | phosphatase activity | 5 | 2 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 133 | 137 | PF00656 | 0.340 |
CLV_C14_Caspase3-7 | 151 | 155 | PF00656 | 0.368 |
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.416 |
CLV_NRD_NRD_1 | 68 | 70 | PF00675 | 0.340 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.416 |
CLV_PCSK_KEX2_1 | 68 | 70 | PF00082 | 0.275 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.340 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.191 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.209 |
DEG_APCC_DBOX_1 | 96 | 104 | PF00400 | 0.340 |
DOC_CYCLIN_RxL_1 | 20 | 31 | PF00134 | 0.340 |
DOC_CYCLIN_RxL_1 | 97 | 106 | PF00134 | 0.318 |
DOC_MAPK_MEF2A_6 | 203 | 211 | PF00069 | 0.395 |
DOC_MAPK_MEF2A_6 | 22 | 29 | PF00069 | 0.336 |
DOC_MAPK_NFAT4_5 | 22 | 30 | PF00069 | 0.340 |
DOC_PP2B_LxvP_1 | 163 | 166 | PF13499 | 0.289 |
DOC_PP4_FxxP_1 | 38 | 41 | PF00568 | 0.340 |
DOC_PP4_FxxP_1 | 67 | 70 | PF00568 | 0.275 |
DOC_PP4_FxxP_1 | 9 | 12 | PF00568 | 0.549 |
LIG_14-3-3_CanoR_1 | 143 | 147 | PF00244 | 0.274 |
LIG_14-3-3_CanoR_1 | 22 | 26 | PF00244 | 0.340 |
LIG_14-3-3_CanoR_1 | 223 | 231 | PF00244 | 0.496 |
LIG_14-3-3_CanoR_1 | 86 | 95 | PF00244 | 0.340 |
LIG_APCC_ABBAyCdc20_2 | 22 | 28 | PF00400 | 0.340 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.552 |
LIG_EVH1_2 | 5 | 9 | PF00568 | 0.550 |
LIG_FHA_1 | 143 | 149 | PF00498 | 0.273 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.340 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.173 |
LIG_FHA_2 | 173 | 179 | PF00498 | 0.340 |
LIG_FHA_2 | 200 | 206 | PF00498 | 0.414 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.323 |
LIG_FHA_2 | 53 | 59 | PF00498 | 0.283 |
LIG_FHA_2 | 8 | 14 | PF00498 | 0.548 |
LIG_FHA_2 | 87 | 93 | PF00498 | 0.275 |
LIG_LIR_Gen_1 | 24 | 34 | PF02991 | 0.318 |
LIG_LIR_Nem_3 | 123 | 128 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 13 | 18 | PF02991 | 0.666 |
LIG_LIR_Nem_3 | 49 | 54 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 61 | 67 | PF02991 | 0.274 |
LIG_REV1ctd_RIR_1 | 6 | 11 | PF16727 | 0.546 |
LIG_SH2_CRK | 125 | 129 | PF00017 | 0.454 |
LIG_SH2_CRK | 215 | 219 | PF00017 | 0.436 |
LIG_SH2_PTP2 | 15 | 18 | PF00017 | 0.514 |
LIG_SH2_STAP1 | 115 | 119 | PF00017 | 0.154 |
LIG_SH2_STAP1 | 83 | 87 | PF00017 | 0.275 |
LIG_SH2_STAP1 | 95 | 99 | PF00017 | 0.275 |
LIG_SH2_STAT3 | 157 | 160 | PF00017 | 0.340 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.275 |
LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 221 | 224 | PF00017 | 0.520 |
LIG_SH2_STAT5 | 37 | 40 | PF00017 | 0.284 |
LIG_SH3_3 | 204 | 210 | PF00018 | 0.392 |
LIG_SUMO_SIM_par_1 | 144 | 151 | PF11976 | 0.202 |
LIG_TRAF2_1 | 175 | 178 | PF00917 | 0.275 |
LIG_WW_3 | 4 | 8 | PF00397 | 0.562 |
MOD_CK2_1 | 172 | 178 | PF00069 | 0.282 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.552 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.474 |
MOD_GlcNHglycan | 149 | 153 | PF01048 | 0.312 |
MOD_GSK3_1 | 109 | 116 | PF00069 | 0.475 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.534 |
MOD_N-GLC_1 | 130 | 135 | PF02516 | 0.340 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.305 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.463 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.275 |
MOD_PKA_2 | 142 | 148 | PF00069 | 0.202 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.340 |
MOD_PKA_2 | 222 | 228 | PF00069 | 0.534 |
MOD_Plk_1 | 109 | 115 | PF00069 | 0.390 |
MOD_Plk_1 | 130 | 136 | PF00069 | 0.275 |
MOD_Plk_1 | 29 | 35 | PF00069 | 0.275 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.340 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.202 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.275 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.275 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.340 |
MOD_SUMO_for_1 | 227 | 230 | PF00179 | 0.521 |
TRG_DiLeu_BaEn_1 | 142 | 147 | PF01217 | 0.340 |
TRG_DiLeu_BaLyEn_6 | 124 | 129 | PF01217 | 0.340 |
TRG_ENDOCYTIC_2 | 125 | 128 | PF00928 | 0.335 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.514 |
TRG_ENDOCYTIC_2 | 180 | 183 | PF00928 | 0.376 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.364 |
TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.275 |
TRG_ER_diArg_1 | 67 | 69 | PF00400 | 0.340 |
TRG_Pf-PMV_PEXEL_1 | 101 | 106 | PF00026 | 0.318 |
TRG_Pf-PMV_PEXEL_1 | 194 | 199 | PF00026 | 0.410 |
TRG_Pf-PMV_PEXEL_1 | 23 | 28 | PF00026 | 0.340 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IM73 | Leptomonas seymouri | 55% | 100% |
A0A3Q8IKJ6 | Leishmania donovani | 99% | 100% |
A4HJZ0 | Leishmania braziliensis | 95% | 100% |
A4I7H3 | Leishmania infantum | 99% | 100% |
E9B2D0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
O95476 | Homo sapiens | 29% | 95% |
Q1RMV9 | Bos taurus | 29% | 95% |
Q28HW9 | Xenopus tropicalis | 29% | 95% |
Q29I63 | Drosophila pseudoobscura pseudoobscura | 30% | 95% |
Q3B7T6 | Rattus norvegicus | 29% | 95% |
Q3TP92 | Mus musculus | 29% | 95% |
Q5U395 | Danio rerio | 30% | 94% |
Q5U3T3 | Danio rerio | 30% | 94% |
Q8JIL9 | Xenopus laevis | 29% | 95% |
Q9VRG7 | Drosophila melanogaster | 29% | 95% |